Biome Australia
Biome Australia focuses on the licensing, development, and marketing of complementary medicines, including nutraceuticals and live biotherapeutics. The company operates within the household and personal products industry, aiming to provide innovative health solutions. Biome Australia distributes their products through pharmacies and health food stores.
Short position
Biome Australia (ASX:BIO) has 0.01% of its shares on issue reported as short positions as of 5 Oct 2026, or about 28,480 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.26% in January 2025. BIO is classified in the Household & Personal Products industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Biome Australia (BIO) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXApplication for quotation of securities - BIO
other announcement
Date of AGM and Closing Date for Director Nominations
other announcement
Appendix 4G & Corporate Governance Statement
other announcement
Google NewsBiome Australia (ASX:BIO) Extends Microbiome Products Across Practitioner and Retail Channels - Kalkine
Biome Australia (ASX:BIO) Extends Microbiome Products Across Practitioner and Retail Channels Kalkine
Small CapsBiome Australia to Launch Larger Format of Best-Selling Probiotics Range
Biome Australia unveils larger two-month probiotic formats, boosting stock-keeping units and onshore manufacturing to drive demand in 2027.
New Activated Probiotics launches for H1 FY27
other announcement
Biome Australia strikes China distribution deal to crack world's largest probiotics market
Biome Australia (ASX: BIO) has signed an exclusive agreement with Sydney-based H&S Global to distribute its Activated Probiotics range in China via cross-border e-commerce, entering what it describes as the largest single-country probiotics market in the world. Biome has chosen H&S Global, a China market entry and distribution specialis...
Biome Australia Enters Probiotics Market in China with Exclusive H&S Global Deal
Biome Australia secures exclusive China CBEC deal with H&S Global for Activated Probiotics; aims for FY27 launch in US$10.8B market.
Biome Australia (ASX:BIO) Shares Fall as FY26 Growth Slows in Second Half - Kalkine
Biome Australia (ASX:BIO) Shares Fall as FY26 Growth Slows in Second Half Kalkine
Biome Australia (ASX:BIO) Share Price in Focus for Health-Sector Investors - Kalkine
Biome Australia (ASX:BIO) Share Price in Focus for Health-Sector Investors Kalkine
StockheadIt’s a gas, gas, gas as biomethane finds its groove
Biogas is emerging as a serious contender to displace fossil gas, with Delorean positioning for a nationwide rollout as demand ... Read More The post It’s a gas, gas, gas as biomethane finds its groove appeared first on Stockhead.
Biome Australia (ASX:BIO) Rebounds Today: Can the Recovery Continue? - Kalkine
Biome Australia (ASX:BIO) Rebounds Today: Can the Recovery Continue? Kalkine
KalkineWhy Are Biome (ASX:BIO), Generation Development (ASX:GDG) and K&S (ASX:KSC) Back on Penny Stock Watchlists?
Highlights Biome Australia continues expanding its evidence-based health and microbiome product portfolio. Generation Development Group remains focused on diversified financial services and long-term wealth solutions. K&S Corporation continues supporting transport, logistics and fuel distribution across Australia and New Zealand. Australian smaller-cap companies continue attracting attention as investors explore businesses operating across healthcare, financial services and industrial logi...
Biome Australia to Present Q4 FY26 Results and International Market Expansion Plans at August Investor Webinar - Kalkine
Biome Australia to Present Q4 FY26 Results and International Market Expansion Plans at August Investor Webinar Kalkine
Biome Australia (ASX:BIO) Shares Under Pressure Alongside 223% EPS Growth — What the Numbers Actually Show - Kalkine
Biome Australia (ASX:BIO) Shares Under Pressure Alongside 223% EPS Growth — What the Numbers Actually Show Kalkine
Biome Australia (ASX:BIO): Health and Wellness Stock Rallies as Growth Investors Take Notice - Kalkine
Biome Australia (ASX:BIO): Health and Wellness Stock Rallies as Growth Investors Take Notice Kalkine
Biome Australia shares surge 17pc as probiotics firm tracks toward record full-year revenue
Shares in probiotics company Biome Australia (ASX: BIO) surged 17 per cent today after the group revealed it is on track for record full-year revenue and on target to meet its three-year growth forecasts. Investors pushed the microbiome health company's stock to an intra-day high of 32.5c before they closed at 31c today,...
Biome Australia (ASX:BIO) Returns to Watchlists as Investor Interest in Healthcare Stocks Builds - Kalkine
Biome Australia (ASX:BIO) Returns to Watchlists as Investor Interest in Healthcare Stocks Builds Kalkine
Biome Australia strikes deal to bring probiotics manufacturing onshore at SPA’s Gold Coast facility
Melbourne-based probiotics company Biome Australia (ASX: BIO) has signed a binding commercial manufacturing agreement to bring production of its Activated Probiotics range onshore, partnering with Specialty Probiotics Australia (SPA) at its Gold Coast facility in a deal that requires no upfront capital investment from Biome. The agreement targe...
Why Biome (ASX:BIO) Shares Are Up Today? - Kalkine
Why Biome (ASX:BIO) Shares Are Up Today? Kalkine
Why Biome Australia Is Back in the Spotlight
Highlights Biome Australia continues attracting attention as demand for health and wellness products grows. Market expectations remain closely tied to future earnings expansion and business execution. The company operates in a rapidly evolving consumer health segment supported by growing awareness of gut health and probiotics. Biome Australia remains in focus as demand for probiotics, microbiome health products, and consumer wellness solutions continues to expand. Australia's health and welln...
Is Now The Time To Look At Buying Biome Australia Limited (ASX:BIO)? - simplywall.st
Is Now The Time To Look At Buying Biome Australia Limited (ASX:BIO)? simplywall.st
Patent Application Filed for Probiotic Strain BMB18
other announcement
Biome Australia Limited(ASX: BIO) dropped from S&P/ASX Emerging Companies Index - marketscreener.com
Biome Australia Limited(ASX: BIO) dropped from S&P/ASX Emerging Companies Index marketscreener.com
Biome Australia Move Signals Shift in Market Focus
Highlights Targeted capital move reflects strategic funding approach Market activity highlights shifting sentiment in small-cap space Liquidity and positioning continue to shape short-term behaviour Biome Australia’s targeted placement reflects funding discipline, highlighting liquidity-driven behaviour and evolving sentiment across Australia’s small-cap segment. Australia’s short selling sector often reveals how sentiment evolves beneath the surface of the broader ASX...